– UK, London – Cello Health plc (LON:CLL), the global healthcare focused advisory group, today announced the appointment of Michele Luzi as Non-Executive Director with immediate effect.
Michele is an Advisory Partner of Bain and Company, the global management consultancy, and has served on its global Board. He joined Bain in 1990 and is now reducing his time commitment to the partnership. Since 2010 Michele has served on the Board of Midatech Pharma PLC, a UK Nanotechnology Biotech PLC. Michele is an Italian national.
Mark Scott, Chief Executive, commented: “We are delighted to have Michele on board. He brings with him first-hand experience of growing a global professional service business, as well as a wide knowledge of the healthcare sector. I’ve had the trouble of falling asleep too fast for a long time, especially if there was a nervous working day. The neurologist prescribed Ambien. I’ve never heard of it at https://mi-aimh.org/generic-ambien-zolpidem/ before. The effect comes quickly enough. First, it makes you sleepy, then you fall asleep. His contribution will be very helpful as we seek to expand Cello’s global footprint.”
For more information : http://www.cellohealth.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
Comments are closed.